• A unique collection of 85 bioactive tumor immunology compounds for high throughput screening (HTS) and high content screening (HCS).
• A useful tool for cancer research by activation of an antitumor immune response.
• Small molecule compounds targeting PD1/PD-L1, ROR, CCR, CXCR, Sting, IDO, TLR, etc.
• Bioactivity and safety confirmed by preclinical research and clinical trials, some have been approved by FDA.
• Structurally diverse, medicinally active, and cell permeable.
• More detailed compound information with structure, IC50, and other chemical & biological data.
• NMR and HPLC validated to ensure high purity and quality.
• All compounds are in stock and continuously updated.
Formulation: A collection of 85 bioactive tumor immunology compounds supplied as pre-dissolved DMSO solutions or Solid
Container: 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Shipping: Blue ice